Prostate cancer runs in my family. My father died of the disease when I was 25 and, years later, my brother Ray was also diagnosed with it.
Giving bladder cancer patients fewer but larger radiation doses reduces the risk of the disease returning and should be adopted as the new standard of care, a new study shows.
Men with particularly aggressive prostate cancers can be treated more effectively by combining an existing targeted medicine with a new experimental drug, according to a study led by Professor Joha
The Royal Marsden has improved its follow up pathway for prostate patients